Upper GI bleed: peptic ulcer: treating H. pylori infections reduced recurrence more effectively than long-term ranitidine
|
|
|
Clinical bottom line (level 1b)
-
Patients with a recent upper GI bleed from an H.pylori-infected peptic ulcer who had triple therapy compared with long-term ranitidine were less likely to develop recurrent ulcers
(NNT =
15
at 12
months)
-
There was no clear difference in the rate of ulcer healing.
-
There was no clear effect on the recurrence of bleeding peptic ulcers.
|
|
Sung et al:
Digestive Diseases and Sciences
1997;
42 (12):
2524-2528
|
Expires October 2002
|
The study
Unblinded ?concealed randomised
trial
without
intention-to-treat
Setting: university hospital, Hong Kong
247 patients
(aged
mean 45,
82%
male)
with an upper GI bleed due to an endoscopically-proven peptic ulcer, and a positive urease test for H. pylori.
Excluded if
- aged <16
- history of using NSAIDs in last 8 weeks
- previous ulcer surgery or H.pylori therapy
- pregnancy
Control Group: (n = 124, 121 analysed):
long-term ranitidine 300 mg po bd for 6 weeks, then 150 mg daily
Experimental Group: (n = 123, 123 analysed):
H. pylori eradication therapy: one-week course of bismuth subcitrate 120 mg qds, metronidazole 400 mg qds and tetracycline 500 mg qds. Patients had 300 mg ranitidine daily for that week.
99% followed for
12
months
Outcome notes:
-
ulcer not healed
: on repeat endoscopy
The evidence
| Outcome |
Time to outcome |
CER | EER | RRR (95% CI) | ARR (95% CI) | NNT (95% CI) |
| ulcer not healed
|
6
weeks |
17 (14.1%) |
15 (11.9%) |
15% (-62% to
56%) |
2.14% (-6.24% to
10.5%) |
47
(NNT = 9 to infinity;
NNH =
16
to infinity)
|
| recurrence of ulcer
|
12
months |
9 (%) |
1 (.79%) |
89% (17% to
99%) |
6.64% (1.7% to
12%) |
15
(9 to
58)
|
| recurrent bleeding ulcers
|
12
months |
3 (2.48%) |
0 (0.0%) |
100% (0% to
100%) |
2.48% (-0.29% to
5.25%) |
40
(NNT = 19 to infinity;
NNH =
340
to infinity)
|
Comments
- The study is too small to show any effect on the recurrence of bleeding ulcers.
Citation
-
Sung
JJ,
Leung
WK,
Suen
R, et al:
one-week antibiotics versus maintenance acid suppression therapy for Helicobacter pylori-associated peptic ulcer bleeding.
Digestive Diseases and Sciences
1997;
42 (12):
2524-2528
Contributor: Chris Ball and Musab Hayatli, October 1999
Reviewer:
Clinical Question.
| Patient |
upper GI bleed from a peptic ulcer with a H.pylori infection |
| Intervention or Exposure |
triple therapy |
| Comparison |
long-term ranitidine |
| Outcome |
ulcer recurrence |
|
|